Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess
Cardiovascular diagnostic device developer Accumetrics has begun shipping its Ultegra point-of-care diagnostic system, designed to measure platelet function in patients undergoing coronary interventional procedures. The portable device can assess platelet function at the bedside from a whole blood sample in less than two minutes, according to the San Diego-based company, and enables cardiologists to measure the effects of certain inhibitors in the cardiac cath lab. The Ultegra system is intended to serve as a platform for other point-of-care diagnostic applications Accumetrics intends to bring to market, according to Terry Johnson, president and CEO.